← Back to Search

Exercise Program for Breast Cancer Fatigue

N/A
Recruiting
Led By Priya P Gor, MD, MSCE
Research Sponsored by Virtua Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
ECOG performance score < 3
Age > 18 years
Must not have
Coronary artery disease, not cleared by cardiologist
Chronic fatigue syndrome
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6 following completion of chemotherapy
Awards & highlights
No Placebo-Only Group

Summary

This trial tests how home exercise can reduce fatigue in people with breast cancer receiving chemotherapy. Subjects use a mobile device to report outcomes weekly.

Who is the study for?
This trial is for English-speaking women over 18 with breast cancer, planning to undergo at least 4 chemotherapy cycles. They must be able to exercise (if cleared by a cardiologist), have an ECOG score <3, and own a device like a smartphone for reporting. It's not for those with exercise contraindications or certain medical/psychiatric conditions.
What is being tested?
The study tests if home exercises can reduce fatigue in breast cancer patients during chemotherapy. Participants are randomly assigned to either control (no exercise) or intervention (exercise) groups, and they report their fatigue levels using specific tools online throughout the treatment period.
What are the potential side effects?
Since this trial involves an exercise program rather than medication, side effects may include typical physical responses to exercise such as muscle soreness or strain especially when starting new routines or increasing intensity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can take care of myself but may not be able to do heavy physical work.
Select...
I am older than 18 years.
Select...
I am a woman planning to undergo at least 4 chemotherapy cycles for breast cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have heart artery disease not approved by a heart doctor.
Select...
I have been diagnosed with chronic fatigue syndrome.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6 following completion of chemotherapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 following completion of chemotherapy for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Determine the feasibility of a specific home-based exercise program in reducing cancer-related fatigue.
Secondary study objectives
To quantify the change over time in PRO-CTCAE derived symptoms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExerciseExperimental Treatment1 Intervention
Intervention: Subject will be assessed by a Physical Therapist. Based on the assessment, the Physical Therapist will provide the patient with a home-based exercise program including core exercises as follows: Core Stabilization, core extension, leg extensions, squats with and without weights, shoulder and arm exercises. Patients will be asked to complete a symptom survey weekly via a web-based platform for tracking cancer and treatment-related symptoms and fatigue.
Group II: ControlActive Control1 Intervention
Subject will not be provided an exercise program but will be asked to complete the symptom survey weekly via a web-based platform for tracking cancer and treatment-related symptoms and fatigue.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~820

Find a Location

Who is running the clinical trial?

Virtua Health, Inc.Lead Sponsor
9 Previous Clinical Trials
647 Total Patients Enrolled
Carevive Systems, Inc.Industry Sponsor
15 Previous Clinical Trials
1,014 Total Patients Enrolled
4 Trials studying Breast Cancer
201 Patients Enrolled for Breast Cancer
Priya P Gor, MD, MSCEPrincipal InvestigatorPenn Medicine

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05704842 — N/A
Breast Cancer Research Study Groups: Exercise, Control
Breast Cancer Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT05704842 — N/A
Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05704842 — N/A
~12 spots leftby Dec 2025